Archive for the ‘wiley retractions’ Category
Former University of Tokyo researcher Shigeaki Kato continues to put big numbers on the board.
Last month, we reported on his 26th, 27th, and 28th retractions, all in Nature Cell Biology and cited close to 700 times. Yesterday, EMBO Journal and EMBO Reports published a total of five more retractions for the endocrinology researcher, who resigned from the university in 2012 following investigations found he had faked images.
This summer, a scientist exploited basic security flaws in how the system accepts author suggestions for peer reviewers to review a whole pile of his own manuscripts, ultimately resulting in the retraction of 60 papers and the resignation of the Taiwan minister of education.
Now, another journal that uses the system, Wiley’s International Journal of Chemical Kinetics, has retracted a paper because the authors provided their own peer reviewers and “the identity of the peer reviewers could subsequently not be verified.”
We asked editor Craig A. Taatjes if he was concerned the authors had conducted their own peer review. His response is reflective of many of the breaches we’ve seen so far for these online systems: Read the rest of this entry »
Some, though, we’re just not qualified to understand, like this retracted paper in the Journal of Management Studies, which according to the abstract “demonstrates that the persistence of brokerage positions decreases broker performance.”
What is clear is the retraction: the author already published the conclusion in a Japanese management journal in 2011.
A group of liver researchers from the University of Pittsburgh has earned a pair of corrections in Hepatology for image problems.
The team was led by George K. Michalopoulos, chair of the department of pathology at the University of Pittsburgh Medical Center.
One article, “Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene,” appeared in January 2011. According to the notice: Read the rest of this entry »
A paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.
Two papers on “novel techniques” have been retracted with what is unfortunately a very non-novel technique: an odd notice and silence when we asked for comment.
Here’s the explanation for retraction of “A novel approach to treat residual peridevice leakage after left-atrial appendage closure,” by Wunderlich N, Wilson N, and Sievert H: Read the rest of this entry »
Earlier this month, we brought you the story of a retraction from the Journal of the Association for Information Science and Technology involving rivalry and alleged sock puppetry. The author of the now-retracted letter, physicist Lorenzo Iorio, claimed that another researcher was using fake names to criticize his work on arXiv.At the time, the editor of the journal had told everyone concerned that the letter would be retracted, but the retraction notice hadn’t yet appeared. Now it has.
Ulrich Lichtenthaler, of the University of Mannheim, has notched retractions 14 and 15, both in Entrepreneurship Theory and Practice.
Zoonoses and Public Health has retracted a 2013 paper on bird flu in Myanmar because the authors had published the article previously in a different journal.
The article, “Risks of Avian Influenza (H5) in Duck Farms in the Ayeyarwaddy Delta Region, Myanmar,” was written by a group led by Alongkorn Amonsin, of the Department of Veterinary Public Health at Chulalongkorn University, in Bangkok, Thailand.